Oct 14 (Reuters) - Astria Therapeutics Inc ( ATXS ):
* BIOCRYST TO ACQUIRE ASTRIA THERAPEUTICS, STRENGTHENING
PRESENCE
IN HAE, TRANSFORMING GROWTH PROFILE
* BIOCRYST PHARMACEUTICALS ( BCRX )- DEAL VALUED AT $13.00 PER ASTRIA
SHARE, $700 MILLION ENTERPRISE VALUE
* ASTRIA THERAPEUTICS INC ( ATXS ) - BIOCRYST TO PAY $8.55 CASH AND
0.59
SHARES PER ASTRIA SHARE
* ASTRIA THERAPEUTICS INC ( ATXS ) - BIOCRYST ENTERS $550 MILLION
FINANCING
FACILITY WITH BLACKSTONE
* ASTRIA THERAPEUTICS INC ( ATXS ): EXPECTS CASH PORTION OF DEAL
CONSIDERATION TO BE FUNDED WITH CASH ON HAND & PART OF
BLACKSTONE FACILITY
Source text:
Further company coverage: